CGM
AGN

Capital Growth Management’s Allergan plc AGN Stock Holding History

Capital Growth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-370,000
Closed -$82.5M – 83
2014
Q2 		$82.5M Sell
370,000
-260,000
-41% -$53.8M 2.19% 12
2014
Q1 		$130M Buy
+630,000
New +$125M 3.48% 8

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Growth Management's AGN Position: Q3 2014 in Review

Capital Growth Management sold out of Allergan plc (AGN) in Q3 2014, closing a stake of 370,000 shares — an estimated $82.5M sold.

Capital Growth Management first reported a position in AGN in Q1 2014 and held it in 2 quarters. The position peaked at $130M in Q1 2014. 753 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • Capital Growth Management reported no remaining Allergan plc position as of Q3 2014 after selling out during the quarter.
  • Capital Growth Management sold 370,000 Allergan plc shares in Q3 2014, an estimated $82.5M.
  • Capital Growth Management first reported a position in Allergan plc in Q1 2014 and held it in 2 quarters.
  • Capital Growth Management's Allergan plc position peaked at $130M in Q1 2014.
  • 753 funds tracked by Wall St. Rank held Allergan plc as of Q3 2014.

Based on Capital Growth Management's 13F filing for Q3 2014, filed 13 Nov 2014.